This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Finance & Accounting for Bioscience
September 16-17, 2025
Sheraton BostonBoston, MA

David Towslee
Associate Director, Accounting at Intellia Therapeutics
Speaker

Profile

David Towslee, CPA, is the Associate Director, Accounting at Intellia Therapeutics, a late-state biotechnology company. With almost a decade of experience across multiple biotech organizations and stages of maturity, David’s expertise includes clinical trial and R&D accounting, including complex contracts, collaboration agreements, and manufacturing. David partners with scientific and operational teams to deliver financial insights that drive strategy, while leading process improvements, strengthening controls, and maintaining compliance with SEC requirements. David is a proud graduate of The Ohio State University.

Agenda Sessions

  • Clinical Trials: Effective Financial Management For Driving Success Throughout The Trial Lifecycle

    11:00am

At this event